RedHill Biopharmas Wirkstoffkandidat Opaganib zeigt hemmende Wirkung gegen COVID-19-Varianten in präklinischer Studie ...Middle East

Opaganib zeigt eine stark hemmende Wirkung gegen die COVID-19-Varianten Beta (Südafrika) und Gamma (Brasilien); weiterer Beleg der antiviralen Aktivität des Wirkstoffkandidaten Der einzigartige Ansatz von oral-verabreichtem Opaganib zur Bekämpfung von COVID-19, das auf das Zielmolekül in...

Hence then, the article about redhill biopharmas wirkstoffkandidat opaganib zeigt hemmende wirkung gegen covid 19 varianten in praklinischer studie was published today ( Tuesday 29/06/2021 - 10:45 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( RedHill Biopharmas Wirkstoffkandidat Opaganib zeigt hemmende Wirkung gegen COVID-19-Varianten in präklinischer Studie )

Also on site :

• Two dozen killed in Ukrainian strike on Russian New Year’s celebration – governor
• Volunteer in Iran’s Revolutionary Guard reportedly killed during widening protests
• Palestinian Mujahideen Movement Condemns Israeli Enemy& 039;s Prevention of International Organizations from Continuing Their Work